La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Labcorp Holdings Gestione
Gestione criteri di controllo 4/4
Labcorp Holdings' Il CEO è Adam Schechter, nominato in Nov2019, e ha un mandato di 4.75 anni. la retribuzione annua totale è $ 15.98M, composta da 8.6% di stipendio e 91.4% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.11% delle azioni della società, per un valore di $ 21.30M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 4.6 anni e 9.4 anni.
Informazioni chiave
Adam Schechter
Amministratore delegato
US$16.0m
Compenso totale
| Percentuale dello stipendio del CEO | 8.6% |
| Mandato del CEO | 4.8yrs |
| Proprietà del CEO | 0.1% |
| Durata media del management | 4.6yrs |
| Durata media del Consiglio di amministrazione | 9.4yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Investors Still Waiting For A Pull Back In Labcorp Holdings Inc. (NYSE:LH)
Jul 20
Laboratory Corporation: Limited Upside Visibility, Reiterate Hold
Jun 21When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?
Jun 13Here's Why It's Unlikely That Laboratory Corporation of America Holdings' (NYSE:LH) CEO Will See A Pay Rise This Year
May 08Laboratory Corporation of America Holdings (NYSE:LH) Is Paying Out A Dividend Of $0.72
Apr 30Laboratory Corporation of America Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72
Apr 15Laboratory Corporation of America Holdings' (NYSE:LH) P/E Is On The Mark
Apr 06Laboratory Corporation: A Healthier Diagnosis, As Pandemic Headwinds Disappear
Apr 01Laboratory Corporation of America Holdings (NYSE:LH) Will Pay A Dividend Of $0.72
Feb 25We Think You Can Look Beyond Laboratory Corporation of America Holdings' (NYSE:LH) Lackluster Earnings
Feb 22An Intrinsic Calculation For Laboratory Corporation of America Holdings (NYSE:LH) Suggests It's 48% Undervalued
Feb 21Laboratory Corporation of America Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72
Jan 31Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly
Jan 30Laboratory Corporation of America Holdings' (NYSE:LH) Dividend Will Be $0.72
Jan 15Some Shareholders Feeling Restless Over Laboratory Corporation of America Holdings' (NYSE:LH) P/E Ratio
Jan 05Laboratory Corporation: Multiple Updates, Same Investment Conclusion
Dec 02Laboratory Corp.: Rate On Capital Deployed Contracting, Hold
Sep 14Laboratory Corporation: Trying To Create Value By Spinning Out Fortrea
Jul 05Newsflash: Laboratory Corporation of America Holdings (NYSE:LH) Analysts Have Been Trimming Their Revenue Forecasts
Jul 04Are Investors Undervaluing Laboratory Corporation of America Holdings (NYSE:LH) By 43%?
Jun 23Laboratory Corporation: Predictability Of Cash Flows Less Visible
Jun 21Is It Too Late To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?
May 26Laboratory Corporation of America Holdings' (NYSE:LH) Returns On Capital Are Heading Higher
Mar 16Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 32% Below Their Intrinsic Value Estimate
Mar 02Laboratory Corporation of America Non-GAAP EPS of $4.14 in-line, revenue of $3.7B misses by $40M, introduces FY23 outlook
Feb 16At US$254, Is It Time To Put Laboratory Corporation of America Holdings (NYSE:LH) On Your Watch List?
Jan 30Laboratory Corporation: Plenty Of Growth Runway
Jan 19Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$450m |
| Mar 31 2024 | n/a | n/a | US$399m |
| Dec 31 2023 | US$16m | US$1m | US$379m |
| Sep 30 2023 | n/a | n/a | US$583m |
| Jun 30 2023 | n/a | n/a | US$677m |
| Mar 31 2023 | n/a | n/a | US$789m |
| Dec 31 2022 | US$15m | US$1m | US$1b |
| Sep 30 2022 | n/a | n/a | US$2b |
| Jun 30 2022 | n/a | n/a | US$2b |
| Mar 31 2022 | n/a | n/a | US$2b |
| Dec 31 2021 | US$21m | US$1m | US$2b |
| Sep 30 2021 | n/a | n/a | US$3b |
| Jun 30 2021 | n/a | n/a | US$3b |
| Mar 31 2021 | n/a | n/a | US$3b |
| Dec 31 2020 | US$15m | US$1m | US$2b |
| Sep 30 2020 | n/a | n/a | US$845m |
| Jun 30 2020 | n/a | n/a | US$362m |
| Mar 31 2020 | n/a | n/a | US$321m |
| Dec 31 2019 | US$6m | US$208k | US$824m |
| Sep 30 2019 | n/a | n/a | US$755m |
| Jun 30 2019 | n/a | n/a | US$853m |
| Mar 31 2019 | n/a | n/a | US$896m |
| Dec 31 2018 | US$301k | n/a | US$884m |
| Sep 30 2018 | n/a | n/a | US$1b |
| Jun 30 2018 | n/a | n/a | US$1b |
| Mar 31 2018 | n/a | n/a | US$1b |
| Dec 31 2017 | US$290k | n/a | US$1b |
Compensazione vs Mercato: La retribuzione totale di Adam ($USD 15.98M ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 13.21M ).
Compensazione vs guadagni: La retribuzione di Adam è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Adam Schechter (59 yo)
4.8yrs
Mandato
US$15,979,355
Compensazione
Mr. Adam H. Schechter serves as the President, CEO & Chairman of Laboratory Corporation of America Holdings. Mr. Adam serves as President & Chief Executive Officer at Labcorp Holdings Inc. since November...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 4.8yrs | US$15.98m | 0.11% $ 21.2m | |
| CFO & Executive VP | 10.2yrs | US$4.96m | 0.055% $ 10.5m | |
| Executive VP | 1.3yrs | US$3.80m | 0.0060% $ 1.1m | |
| EVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer | 1.3yrs | US$3.48m | 0.033% $ 6.3m | |
| Executive VP & Chief Human Resources Officer | 1.3yrs | US$2.56m | 0.00035% $ 66.5k | |
| Senior VP & Chief Accounting Officer | 5.3yrs | Nessun dato | 0.0025% $ 472.8k | |
| Executive VP and Chief Information & Technology Officer | 10.5yrs | US$2.70m | 0.019% $ 3.6m | |
| Vice President of Investor Relations | no data | Nessun dato | Nessun dato | |
| Executive VP | 5.5yrs | Nessun dato | 0.0067% $ 1.3m | |
| Executive VP & Chief Marketing Officer | 4.4yrs | Nessun dato | 0.0047% $ 898.2k | |
| Enterprise Chief Scientific Officer & Senior VP | no data | Nessun dato | Nessun dato | |
| Chief Medical Officer | 3.6yrs | Nessun dato | Nessun dato |
4.6yrs
Durata media
60yo
Età media
Gestione esperta: Il team dirigenziale di LH è considerato esperto (durata media dell'incarico 4.6 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 11.3yrs | US$15.98m | 0.11% $ 21.2m | |
| Independent Director | 11.6yrs | US$357.87k | 0.014% $ 2.7m | |
| Independent Director | 18.3yrs | US$340.73k | 0.018% $ 3.4m | |
| Lead Independent Director | 10.7yrs | US$375.73k | 0.014% $ 2.7m | |
| Independent Director | 8.5yrs | US$341.44k | 0.010% $ 1.9m | |
| Independent Director | 10.3yrs | US$330.01k | 0.010% $ 2.0m | |
| Independent Director | 4.7yrs | US$344.30k | 0.0043% $ 818.4k | |
| Independent Director | 1.2yrs | US$208.42k | 0.00087% $ 165.2k | |
| Independent Director | 3.4yrs | US$330.01k | 0.0027% $ 518.4k | |
| Independent Director | 1.8yrs | US$330.01k | 0.0016% $ 298.1k |
9.4yrs
Durata media
60yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di LH sono considerati esperti (durata media dell'incarico 9.4 anni).